- Hardenbrook NJ, Zhang P. A structural view of the SARS-CoV-2 virus and its assembly. Current Opinion in Virology. 2022; 52:123-34.
- Rochman ND, Wolf YI, Faure G, Mutz P, Zhang F, Koonin EV. Ongoing global and regional adaptive evolution of SARS-CoV-2. Proceedings of the National Academy of Sciences. 2021; 118(29):e2104241118.
- Li Q, Wu J, Nie J, Zhang L, Hao H, Liu S, et al. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell. 2020; 182(5):1284-94.e9.
- Nguyen TT, Pathirana PN, Nguyen T, Nguyen QVH, Bhatti A, Nguyen DC, et al. Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus). Scientific Reports. 2021; 11(1):3487.
- Hirabara SM, Serdan TDA, Gorjao R, Masi LN, Pithon-Curi TC, Covas DT, et al. SARS-COV-2 Variants: Differences and Potential of Immune Evasion. Frontiers in cellular and infection microbiology. 2021; 11:781429.
- Altmann DM, Boyton RJ, Beale R. Immunity to SARS-CoV-2 variants of concern. Science (New York, NY). 2021; 371(6534):1103-4.
- Mistry P, Barmania F, Mellet J, Peta K, Strydom A, Viljoen IM, et al. SARS-CoV-2 Variants, Vaccines, and Host Immunity. Frontiers in immunology. 2021; 12:809244.
- Focosi D, Maggi F. Neutralizing antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines. Reviews in medical virology. 2021; 31(6):e2231.
- Tomaszewski T, DeVries RS, Dong M, Bhatia G, Norsworthy MD, Zheng X, et al. New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release. bioRxiv. 2020:2020.07.31.231472.
- Woo J, Lee EY, Lee M, Kim T, Cho YE. An in vivo cell-based assay for investigating the specific interaction between the SARS-CoV N-protein and its viral RNA packaging sequence. Biochemical and biophysical research communications. 2019; 520(3):499-506.
- Oliveira SC, de Magalhães MTQ, Homan EJ. Immunoinformatics Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets. Frontiers in immunology. 2020; 11:587615.
- Mohammad T, Choudhury A, Habib I, Asrani P, Mathur Y, Umair M, et al. Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach. Front Cell Infect Microbiol. 2021; 11:765039.
- Rodriguez-Rivas J, Croce G, Muscat M, Weight M. Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes. Proceedings of the National Academy of Sciences. 2022; 119(4):e2113118119.
- Das JK, Thakuri B, MohanKumar K, Roy S, Sljoka A, Sun G-Q, et al. Mutation-Induced Long-Range Allosteric Interactions in the Spike Protein Determine the Infectivity of SARS-CoV-2 Emerging Variants. ACS Omega. 2021; 6(46):31305-20.
- Fung TS, Liu DX. Post-translational modifications of coronavirus proteins: roles and function. Future virology. 2018; 13(6):405-30.
- Mohammad T, Choudhury A, Habib I, Asrani P, Mathur Y, Umair M, et al. Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach. Front Cell Infect Microbiol. 2021; 11:765039-.
- Al-Zyoud W, Haddad H. Dynamic’s prediction of emerging notable spike protein mutations in SARS-CoV-2 implies a need for updated vaccines. Biochimie. 2021; 191:91-103.
- Chambers JP, Yu J, Valdes JJ, Arulanandam BP. SARS-CoV-2, Early Entry Events. J Pathog. 2020; 2020:9238696-.
- Giron CC, Laaksonen A, Barroso da Silva FL. Up State of the SARS-COV-2 Spike Homotrimer Favors an Increased Virulence for New Variants. Front Med Technol. 2021; 3:694347-.
- Mori T, Jung J, Kobayashi C, Dokainish HM, Re S, Sugita Y. Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein. Biophysical Journal. 2021; 120(6):1060-71.
- Quaglia F, Salladini E, Carraro M, Minervini G, Tosatto SCE, Le Mercier P. SARS-CoV-2 variants preferentially emerge at intrinsically disordered protein sites helping immune evasion. The FEBS journal. 2022.
- Tenchov R, Zhou QA. Intrinsically Disordered Proteins: Perspective on COVID-19 Infection and Drug Discovery. ACS Infectious Diseases. 2022; 8(3):422-32.
- Bai Z, Cao Y, Liu W, Li J. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation. Viruses. 2021; 13(6):1115.
- Azad GK. Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2. PeerJ. 2021; 9:e10666.
- Zhao X, Nicholls JM, Chen YG. Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling. The Journal of biological chemistry. 2008; 283(6):3272-80.
- Ferreira-Gomes M, Kruglov A, Durek P, Heinrich F, Tizian C, Heinz GA, et al. SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself. Nature Communications. 2021; 12(1):1961.
- Mu J, Fang Y, Yang Q, Shu T, Wang A, Huang M, et al. SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2. Cell Discov. 2020; 6:65-.
- Chen K, Xiao F, Hu D, Ge W, Tian M, Wang W, et al. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production. Viruses. 2020; 13(1):47.
- Rodrigues CH, Pires DE, Ascher DB. DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic acids research. 2018; 46(W1):W350-w5.
- Worth CL, Preissner R, Blundell TL. SDM--a server for predicting effects of mutations on protein stability and malfunction. Nucleic acids research. 2011; 39(Web Server issue):W215-W22.
- Chen C-W, Lin M-H, Liao C-C, Chang H-P, Chu Y-W. iStable 2.0: Predicting protein thermal stability changes by integrating various characteristic modules. Comput Struct Biotechnol J. 2020; 18:622-30.
- Seifi M, Walter MA. Accurate prediction of functional, structural, and stability changes in PITX2 mutations using in silico bioinformatics algorithms. PLOS ONE. 2018; 13(4):e0195971.
- Laimer J, Hofer H, Fritz M, Wegenkittl S, Lackner P. MAESTRO - multi agent stability prediction upon point mutations. BMC Bioinformatics. 2015; 16(1):116.
- Kim Y, Ponomarenko J, Zhu Z, Tamang D, Wang P, Greenbaum J, et al. Immune epitope database analysis resource. Nucleic acids research. 2012; 40(Web Server issue):W525-30.
- Christoffer C, Bharadwaj V, Luu R, Kihara D. LZerD Protein-Protein Docking Webserver Enhanced With de novo Structure Prediction. Frontiers in molecular biosciences. 2021; 8:724947.
- Weng G, Wang E, Wang Z, Liu H, Zhu F, Li D, et al. HawkDock: a web server to predict and analyze the protein-protein complex based on computational docking and MM/GBSA. Nucleic acids research. 2019; 47(W1):W322-w30.
- Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, et al. The ClusPro web server for protein-protein docking. Nature protocols. 2017; 12(2):255-78.
- Land H, Humble MS. YASARA: A Tool to Obtain Structural Guidance in Biocatalytic Investigations. Methods in molecular biology (Clifton, NJ). 2018; 1685:43-67.
- Xue LC, Rodrigues JP, Kastritis PL, Bonvin AM, Vangone A. PRODIGY: a web server for predicting the binding affinity of protein-protein complexes. Bioinformatics (Oxford, England). 2016; 32(23):3676-8.
- Ye Q, West AMV, Silletti S, Corbett KD. Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein. Protein science: a publication of the Protein Society. 2020; 29(9):1890-901.
- Johnson BA, Zhou Y, Lokugamage KG, Vu MN, Bopp N, Crocquet-Valdes PA, et al. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis. bioRxiv. 2021:2021.10.14.464390.
- Hernandez-Alias X, Schaefer MH, Serrano L. Translational adaptation of human viruses to the tissues they infect. bioRxiv. 2020:2020.04.06.027557.
- Chen C, Boorla VS, Banerjee D, Chowdhury R, Cavener VS, Nissly RH, et al. Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2. Proceedings of the National Academy of Sciences. 2021; 118(42):e2106480118.
- Wu H, Xing N, Meng K, Fu B, Xue W, Dong P, et al. Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2. Cell Host Microbe. 2021; 29(12):1788-801.e6.
- Davies NG, Jarvis CI, van Zandvoort K, Clifford S, Sun FY, Funk S, et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature. 2021; 593(7858):270-4.
- Washington NL, Gangavarapu K, Zeller M, Bolze A, Cirulli ET, Schiabor Barrett KM, et al. Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States. Cell. 2021; 184(10):2587-94.e7.
- Socher E, Conrad M, Heger L, Paulsen F, Sticht H, Zunke F, et al. Mutations in the B.1.1.7 SARS-CoV-2 Spike Protein Reduce Receptor-Binding Affinity and Induce a Flexible Link to the Fusion Peptide. Biomedicines. 2021; 9(5).
- Lubinski B, Fernandes MHV, Frazier L, Tang T, Daniel S, Diel DG, et al. Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. bioRxiv: the preprint server for biology. 2021:2021.04.06.438731.
- Mohammad A, Abubaker J, Al-Mulla F. Structural modeling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity. Virus Res. 2021; 303:198522.
|